US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lexaria Bioscience Corp

0.0012

0.0000

Volume:- -

Turnover:- -

Market Cap:6.13K

PE:0.00

High:0.0012

Open:0.0012

Low:0.0012

Close:0.0012

52wk High:0.5000

52wk Low:0.0009

Shares:5.10M

Float Shares:5.10M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6613

ROE:-155.23%

ROA:-82.96%

PB:0.00

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Lexaria Bioscience Corp

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

- -

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LEXXW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"LEXXW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LEXXW\",,,,,undefined,":{"symbol":"LEXXW","market":"US","secType":"STK","nameCN":"Lexaria Bioscience Corp","latestPrice":0.0012,"timestamp":1770670800000,"preClose":0.0012,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":5104300,"shares":5104300,"eps":-0.6613,"marketStatus":"Closed","change":0,"latestTime":"02-09 16:00:00 EST","open":0.0012,"high":0.0012,"low":0.0012,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.6613,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0012,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LEXXW\",,,,,undefined,":{"symbol":"LEXXW","floatShares":5104300,"roa":"-82.96%","roe":"-155.23%","lyrEps":0,"shares":5104300,"dividePrice":0,"high":0.0012,"amplitude":0,"preClose":0.0012,"low":0.0012,"week52Low":0.0009,"pbRate":"0.00","psRate":"0.01","week52High":0.5,"institutionHeld":0,"latestPrice":0.0012,"eps":-0.6613,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.6613,"open":0.0012,"prevYearClose":0.0042,"prevWeekClose":0.0012,"prevMonthClose":0.0012,"prevQuarterClose":0.0042,"fiveDayClose":0.0012,"twentyDayClose":0.0051,"sixtyDayClose":0.0469},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LEXXW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LEXXW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LEXXW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.8788},{"period":"3month","weight":-0.9732},{"period":"6month","weight":-0.9914},{"period":"1year","weight":-0.996},{"period":"ytd","weight":-0.7143}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.124111},{"month":2,"riseRate":0.333333,"avgChangeRate":0.002117},{"month":3,"riseRate":0.8,"avgChangeRate":0.319487},{"month":4,"riseRate":0.4,"avgChangeRate":-0.110679},{"month":5,"riseRate":0.4,"avgChangeRate":-0.108188},{"month":6,"riseRate":0.4,"avgChangeRate":-0.16829},{"month":7,"riseRate":0.6,"avgChangeRate":0.114405},{"month":8,"riseRate":0.8,"avgChangeRate":0.196005},{"month":9,"riseRate":0,"avgChangeRate":-0.283259},{"month":10,"riseRate":0.2,"avgChangeRate":-0.193739},{"month":11,"riseRate":0.8,"avgChangeRate":0.376704},{"month":12,"riseRate":0.2,"avgChangeRate":-0.297972}],"exchange":"NASDAQ","name":"Lexaria Bioscience Corp","nameEN":"Lexaria Bioscience Corp"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LEXXW\",market:\"US\",,,undefined,":null}}